Home > Healthcare & Medical Devices > Clinical Nutrition Market

Clinical Nutrition Market Size By Product (Infant Nutrition {Milk Based, Soy Based, Organic Formulas}, Enteral Nutrition {Standard Composition, Disease Specific Composition}, Parenteral Nutrition {Amino Acids, Fats, Carbohydrates}), By Consumer (Pediatric, Adult), By Application (Cancer, Metabolic Disorders, Neurological Diseases, Gastrointestinal Disorders), By Distribution Channel (Retail Stores, Pharmacies & Drug Stores, Online Channels), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2022 – 2028

  • Report ID: GMI1324
  • Published Date: Mar 2022
  • Report Format: PDF

Industry Overview

Clinical Nutrition Market size garnered a revenue of around USD 47,880 million in 2021 and is projected to reach over USD 83,960 million through 2028 owing to numerous driving factors such as rising cases of metabolic and chronic diseases, unhealthy dietary habits leading to malnourishment, surge in geriatric population, increasing number of pre- mature births and rise in adoption of home healthcare model.

Clinical Nutrition Market

Get more details on this report - Request Free Sample PDF

The developing countries shows considerably high instances of these premature births that could be due to economic strains and high population base. According to a 2018 report published by the WHO, in India, over three million infants are prematurely born that accounts for around 13% of the total births in the country each year.

Clinical nutrition deals with the diagnosis, management and prevention of nutritional and metabolic conditions associated with chronic or acute disorders resulting due to dearth of nutrients and energy. Nutritional assistance is given for a variety of purposes, including reducing the consequences of starvation and improving the response to disease treatment. Clinical nutrition support is certainly required when nutrient assimilation or food intake is reduced for an extended period to prevent starvation and other severe consequences.

However, lack of awareness especially in emerging countries and stringent government regulations are few of the restraints that may result in lower adoption of alternate means of nutrition. The clinical nutrition market growth can be affected in the least developed regions of the world with comparatively lower standards of living attributed to refusal of rationalized means to consume nutrition, lack of acceptance of newer approaches.

The COVID-19 pandemic has emerged into an unanticipated public health hazard, with considerable impact over clinical nutrition industry. The coronavirus outbreak has infected millions of people around the world, resulting in a significant deaths toll. The therapeutic nutrition market has been impacted because of the ongoing COVID-19 pandemic and nationwide lockdowns imposed in various countries.

However, there has been an upsurge in the need for nutritional treatment, as patients with COVID-19 frequently require dietary supplements for a variety of micro and macro nutrients. A report published in the NCBI in 2020 states the importance of sufficient nutrition and dietary correlation during the COVID-19 pandemic has been widely addressed, not only as a means of preventing the onset of noncommunicable diseases, but also as a means of regulating the patients' inflammatory status.

Furthermore, failing to recognise the importance of nutrition in COVID-19, it can have a substantial impact on the prognosis of the patient. As a result, hospitals and clinics have increased their ability to provide healthcare solutions for patients who require disease-specific nutrients. Such developments are expected to increase the adoption of clinical nutrition management in patients, boosting industry statistics in the projected timeframe.

Increasing prevalence of chronic and metabolic diseases across the globe is predicted to drive the business landscape

The increasing prevalence of chronic diseases such as cancer and cardiovascular disorders, malnutrition, respiratory diseases, gastrointestinal diseases among children and adults are contributing to the rising demand for nutritional support. Frequent instances of malnutrition, micronutrient deficiency and dehydration are observed in case of neurological diseases. Diseases like multiple sclerosis, Parkinson's disease, oropharyngeal dysphagia, are few of the examples of such neurological ailments. Oropharyngeal dysphagia, mostly observed in geriatric population, is commonly observed in patients suffering from dementia.

According to a report published by the World Health Organization (WHO) in 2021, around 55 million patients are currently suffering from dementia worldwide and there are 10 million new cases every year. Further, a study published in the NCBI, suggests the occurrence of oropharyngeal dysphagia in dementia patients were 85.9% in 2020. The adoption of clinical nutrition in such cases will help offering the adequate nutritional support and prevent fatalities due to deficiencies. In addition to this, rise in awareness has popularized the use of clinical nutrition products, especially among the developed economies.

Rise in adoption of infant nutrition is anticipated to stimulate the market demand positively

Global Clinical Nutrition Market, By Product

Get more details on this report - Request Free Sample PDF

By product, the clinical nutrition market is segregated as enteral nutrition, infant nutrition, and parenteral nutrition. The infant nutrition segment exceeded USD 26,227 million in 2021 owing to the rise in pre-term births around world. As per the WHO statistics, the range of pre-mature births is around 5-18% across 184 countries in the world.

The dietary needs of a pre-term child are different than a full-term child. Clinical nutrition when administered in neonates, prevents the risk of developmental and growth incapacities and aid in providing immunogenic and metabolic support. Thus, all the above-mentioned factors are anticipated to contribute to driving the infant nutrition segmental growth thereby augmenting overall market share in the foreseeable years.

Surging incidence of malnutrition among children will drive the business revenue and spur the market forecasts

Based on consumer, the clinical nutrition market is segmented as adult and pediatric. The pediatric segment was valued at around USD 28,215 million in 2021 and is expected to witness robust CAGR from 2022 to 2028 owing to the rising prevalence of malnutrition and growing incidences of preterm births globally. According to a report from the WHO, documented in 2020, the mortality rate due to malnutrition in children under 5 years of age was around 45%.

 Additionally, poverty and overpopulation are few other factors involved in the amplification of malnutrition in underdeveloped countries. The most susceptible to the risks are infants and children. Studies support the adoption of clinical nutrients being efficient in providing immediate nutritional support. Moreover, several government and private organizations are coming together to make initiatives to combat under-nutrition in infants.

Growing prevalence of metabolic disorders is projected to enhance the market forecasts

Based on application, the market is segmented as metabolic disorders, cancer, gastrointestinal disorders, neurological diseases, and others. The metabolic disorders segment was valued at more than USD 15,445 million in 2021. The prevalence of metabolic disorders is increasing considerably among the adult and geriatric population. Diseases such as diabetes have been of prime concerns across many countries.

For instance, according to the national diabetic statistic report in 2022 by the Centers for Disease Control and Prevention (CDC), around 37.3 million people suffered from diabetes in the U.S, accounting for 11.3% of the total U.S. population. Nutrition holds a great significance in controlling the metabolic diseases. Clinical nutrition such as monosaturated fat and fiber is administered to patients through Jejunal feeding in instances of patchy bowel dysmotility or symptomatic gastric atony observed in diabetic patients with autonomic neuropathy.

Clinical Nutrition Market Share, By Application

Get more details on this report - Request Free Sample PDF

Increasing preference of retail stores will result in an upward growth trajectory

Based on distribution channel, the clinical nutrition market is segmented as retail stores, online channels, pharmacies & drug stores, and others. The retail stores segment was valued at over USD 20,109 million in 2021 and is expected to expand at a healthy growth rate during the analysis period. Accessibility of clinical nutrition products, brand recognition, and easy availability are some factors that is expected to fuel the overall market size.

Consumers' buying intents and decisions are also influenced by price and promotion information. Clinical nutrition is a type of nutraceutical that requires medical supervision because it considers the eating patterns, metabolic abnormalities, and underlying difficulties of a patient. Few retail stores offer health screenings, educational programs, and nutritional awareness to help the customers combat their ailments. As a result, the aforementioned elements play a key part in a consumer's purchasing decisions, resulting in segmental expansion and, as a result, improves overall industry scenario.

High acceptance of novel products in the North America region will offer unprecedented growth opportunities

Global Clinical Nutrition Market, By Region

Get more details on this report - Request Free Sample PDF

U.S. clinical nutrition market is expected to reach over USD 19,727 million by 2028 due to a number of factors, including an increase in the prevalence of chronic and metabolic diseases, unhealthy dietary habits that lead to malnutrition, increase in the geriatric population, rise in the number of pre-mature births, and growing adoption of home healthcare.

According to a report issued by the National Cancer Institute, around 16,850 children and adolescents were estimated to be diagnosed with cancer in the U.S. in 2020. Patients with cancer suffer with cachexia related muscle wasting and protein calorie malnutrition. Clinical nutrition come in as aide to combat cancer induced cachexia, ensuring immediate nutritional support to prevent starving and other fatal conditions. Additionally, recent advancements in clinical nutrition and the presence of advanced healthcare infrastructure coupled with growing R&D spending related to nutritional products will propel regional market sales.

Notable industry players are focusing on a new product launch that will boost the market growth

Some of the major players operating in the clinical nutrition market are Abbott Laboratories (Abbott Nutrition), B Braun Melsungen AG, Baxter International Inc., Fresenius Kabi, Mead Johnson (Reckitt Benckiser), Nestle Health Science, Perrigo, Pfizer, Inc., Danone, Hero Nutritionals Inc. among others. These leading market players are implementing advanced technologies to cater to the growing demand for highly nutritional products by the consumers.

Recent industry developments:

  • In December 2018, Fresenius Kabi announced that its Omegaven had received an approval from the U.S. FDA. Omegaven is a fish oil triglyceride that aid in offering nutritional support for the paediatric patients suffering through chronic ailments. This approval helps the company to gain a competitive advantage among other players in the market and boost its clinical nutrition product portfolio.
  • In June 2017, Mead Johnson Nutrition Company announced a merger with Reckitt Benckiser Group plc (RB), a manufacturer of nutritional products. This merger helped Mead Johnson to make additions to their already robust product portfolio and strengthen its position in market.

Clinical nutrition market report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2028, for the following segments:

By Product

  • Infant Nutrition
    • Milk Based
    • Soy Based
    • Organic Formulas
    • Others
  • Enteral Nutrition
    • Standard Composition
    • Disease Specific Composition
  • Parenteral Nutrition
    • Amino Acids
    • Fats
    • Carbohydrates
    • Others

By Consumer

  • Pediatric
  • Adult

By Application

  • Cancer
  • Metabolic Disorders
  • Neurological Diseases
  • Gastrointestinal Disorders
  • Others

By Distribution Channel

  • Retail Stores
  • Pharmacies & Drug Stores
  • Online Channels
  • Others

The above information is provided for the following regions and countries:

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE


Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

The clinical nutrition industry generated a revenue of more than USD 47,880 million in 2021 and is anticipated to cross USD 83,960 million by 2028 due to the rising burden of metabolic and chronic diseases along with the expanding geriatric population.

Metabolic disorders contributed close to USD 15,445 million in revenue for the clinical nutrition market in 2021 owing to the growing need to control the spread of the diseases.

The overall market share from the retail store distribution channel had crossed USD 20,109 million in 2021 and will grow due to ease of access to clinical nutrition products, and brand recognition.

U.S. dominates the North American clinical nutrition industry and is expected to account for a revenue of around USD 19,727 million by 2028 impelled by the rising prevalence of chronic and metabolic diseases in the region.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies
Immediate Delivery Available

Premium Report Details

  • Base Year: 2021
  • Companies covered: 10
  • Tables & Figures: 411
  • Countries covered: 18
  • Pages: 250

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount